GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Colorectal ESD Perforation: Endoscopy | July 2026
17

Colorectal ESD Perforation: Endoscopy | July 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2026

Introduction:

Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk factors, and clinical outcomes of colorectal ESD-related perforations.

Why was this study needed?

  • Perforation is the most feared complication of colorectal ESD.
  • Real-world Western data on perforation outcomes are limited.
  • Predictors of perforation and need for surgery remain poorly defined.
  • Better risk stratification can improve patient counseling and procedural planning.
  • Understanding delayed perforation is essential for post-ESD surveillance.

Results:

  • More than 90% of ESD-related perforations were successfully managed conservatively, particularly intraprocedural perforations, avoiding surgery in most patients.
  • Delayed perforation was uncommon but carried a high likelihood of emergency surgery, making early recognition and close post-procedure monitoring critical.
  • Large lesions, severe fibrosis, previous resection, poor endoscope maneuverability, and proximal colonic location significantly increased the risk of perforation.

Clinical Impact:

These findings reassure endoscopists that most intraprocedural perforations can be safely managed endoscopically without surgery. However, delayed perforation remains a serious complication requiring prompt diagnosis and surgical evaluation. Careful patient selection and recognition of high-risk lesions are essential to optimize ESD outcomes.

Bottom Line:

Colorectal ESD perforation is usually manageable without surgery, but delayed perforation remains the major clinical challenge. Patients with large, fibrotic, previously treated, or proximal colonic lesions require heightened procedural caution and close post-procedure surveillance.

Related Q&A

18

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity,...

19

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This...

20

Durable Endoscopic Partial Reversal of Roux-en-Y Gastric Bypass Using Parallel LAMS Septotomy: GIE | July 2026

Introduction: Although Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure, a small proportion of patients develop severe nutritional complications, refractory dumping syndrome, or other debilitating adverse events...

21

EUS Double Drainage for Malignant Dual Obstruction : Gut | Jul 2026

Introduction: Simultaneous malignant distal biliary obstruction (MDBO) and gastric outlet obstruction (GOO), commonly caused by advanced pancreatic, biliary, or duodenal cancers, presents a major palliative challenge. Conventional endoscopic...

22

Endoscopic Mucosal and Submucosal Cutting in benign esophageal stricture: Gut | July 2026

Introduction: Long benign esophageal strictures remain one of the most difficult benign conditions to manage. Although endoscopic dilation and incision techniques provide temporary relief, recurrence is common, often...

23

Economic Impact of POEM and ESD: GIE | June 2026

Introduction: Peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD) have revolutionized the management of esophageal motility disorders and early gastrointestinal neoplasia. Despite their proven clinical benefits, widespread...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer